Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance
J. Liu, Q.-L. He, J. Zhou, R. Chikarmane, G. Hauk, A. Rachakonda, A. M. Vaghasia, N. Castagna, R. C. Steinberg, M.-T. Pham, N. M. Anders, T. M. Wanjiku, P. Nuhn, J. S. Shim, H. Giovinazzo, , S. Yegnasubramanian
This paper identifies triptolide as a compound that enhances the effectiveness of DNMTi by inhibiting DCTPP1, overcoming resistance in cancer cells.
bioRxiv · May 19, 2024Cancer Biology